XERS Cost of Revenue

Xeris Biopharma Holdings Inc · Cost of Revenue

XERS logo

XERS Cost of Revenue

Latest reported$55.87M
XERS Cost of Revenue ($8.00K → $55.87M)
High-resolution chart · PNG

XERS cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
53,412,000
36,832,000
28,645,000
22,634,000
13,318,000
9,328,000
1,603,000
42,000
4,000
8,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.